People · Operator
Named in public records as an officer, director or promoter · active 2013–2023 · Retailing, Healthtech, Biotech / Pharma, Agtech / Foodtech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Naked Brand Group Inc. | — | Retailing | Series A | $10.1M | $1.2M | 2013 |
| Ryu Apparel Inc. | — | Retailing | Seed | $9.5M | $694K | 2020 |
| Comprehensive Healthcare Systems Inc. (Canada) | — | Healthtech | Series A | $7.1M | $401K | 2021 |
| XOStem Biosciences Ltd. | — | Biotech / Pharma | Pre-Seed | $3.3M | $2.2M | 2020 |
| Nepra Foods Inc. | — | Agtech / Foodtech | Pre-Seed | $2.7M | $628K | 2021 |
| Garmatex Technologies, Inc. | — | Other | Pre-Seed | $1.2M | $11.0M | 2014 |
| Nepra Foods, Ltd. | — | Agtech / Foodtech | Pre-Seed | $1.1M | $3.3M | 2020 |
| Vegano Foods Inc. | — | Agtech / Foodtech | Pre-Seed | $308K | $3.4M | 2021 |
| Green Star Biosciences Inc. | — | Biotech / Pharma | Pre-Seed | $250K | $12.8M | 2019 |
ALEX MCAULAY at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ALEX MCAULAY on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Wood | 2 | 8 |
| Chadwick White | 2 | 3 |
| Robert Hopp | 2 | 2 |
| Marc Olmsted | 2 | 2 |
| ANDREW KAPLAN | 1 | 12 |
| DAVID HOCHMAN | 1 | 5 |
| Mark Retzloff | 1 | 5 |
| DALE WALLSTER | 1 | 5 |
| Paul Hayes | 1 | 4 |
| CESARE FAZARI | 1 | 3 |
| John Wood | 1 | 3 |
| JOEL PRIMUS | 1 | 3 |
| Vikas Ranjan | 1 | 3 |
| Gary Yeoman | 1 | 3 |
| BRAD ECKENWEILER | 1 | 3 |
| MARTINO CIAMBRELLI | 1 | 3 |
| Roger Edwards | 1 | 3 |
| Chad White | 1 | 2 |
| William Hogan | 1 | 2 |
| Joel Leonard | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.